An effective vaccine to protect against the Mers virus is a step closer,european scientists genetically modified a version of the smallpox vaccine to display Mers virus protein on its surface.
The vaccine was able to protect camels - the animal reservoir for the virus - from developing Mers virus symptoms. Experts hope the vaccine might stop the virus spreading in camels and may also protect humans at risk from infection.
Infections have been reported in 26 countries around the world with the outbreak epi-centre located in the Arabian Peninsula.There are no treatments for Mers but scientists are trying to develop an effective vaccine. One such scientist is Prof Bart Haagmans, who is based at the Erasmus Medical Centre in the Netherlands. He has been busy developing and testing vaccines in camels.
A team of scientists drawn from the Netherlands, Spain and Germany, genetically engineered a pox virus called Modified Vaccinia Ankara -MVA - to display Mers virus spike protein on its surface. MVA, related to the virus used to eradicate smallpox, was used to eradicate smallpox and is currently being used to develop vaccines to a variety of viruses like influenza, Ebola and hepatitis C. Importantly it can produce antibodies and killer cells.The Mers spike protein is thought to be a major target for the immune response. The team hoped that by cloaking MVA with this spike they would train the immune system to recognize and kill Mers.
The team took the engineered MVA, sprayed it up the noses of camels and injected it into their muscle, and then four weeks later they repeated the vaccination again.
When the team exposed the vaccinated animals to the Mers virus the camels developed very mild symptoms. Crucially they didn't develop a runny nose and the amount of virus they produced was very low.
Camels that hadn't received the vaccine produced very large amounts of virus and suffered a very runny nose. This indicates that even though the vaccine didn't prevent infection it did reduce the amount of virus that the vaccinated camels produced.
story credit BBC news.
Agribusiness, Agriculture, Veterinary Medicine, Cassava, Garri, food security, Agritech and the Red Meat Value Chain.
Showing posts with label immune response. Show all posts
Showing posts with label immune response. Show all posts
Tuesday, December 22, 2015
MERS VACCINE !!!
An effective vaccine to protect against the Mers virus is a step closer,european scientists genetically modified a version of the smallpox vaccine to display Mers virus protein on its surface.
The vaccine was able to protect camels - the animal reservoir for the virus - from developing Mers virus symptoms. Experts hope the vaccine might stop the virus spreading in camels and may also protect humans at risk from infection.
Infections have been reported in 26 countries around the world with the outbreak epi-centre located in the Arabian Peninsula.There are no treatments for Mers but scientists are trying to develop an effective vaccine. One such scientist is Prof Bart Haagmans, who is based at the Erasmus Medical Centre in the Netherlands. He has been busy developing and testing vaccines in camels.
A team of scientists drawn from the Netherlands, Spain and Germany, genetically engineered a pox virus called Modified Vaccinia Ankara -MVA - to display Mers virus spike protein on its surface. MVA, related to the virus used to eradicate smallpox, was used to eradicate smallpox and is currently being used to develop vaccines to a variety of viruses like influenza, Ebola and hepatitis C. Importantly it can produce antibodies and killer cells.The Mers spike protein is thought to be a major target for the immune response. The team hoped that by cloaking MVA with this spike they would train the immune system to recognize and kill Mers.
The team took the engineered MVA, sprayed it up the noses of camels and injected it into their muscle, and then four weeks later they repeated the vaccination again.
When the team exposed the vaccinated animals to the Mers virus the camels developed very mild symptoms. Crucially they didn't develop a runny nose and the amount of virus they produced was very low.
Camels that hadn't received the vaccine produced very large amounts of virus and suffered a very runny nose. This indicates that even though the vaccine didn't prevent infection it did reduce the amount of virus that the vaccinated camels produced.
story credit BBC news.
Subscribe to:
Comments (Atom)
Agribusiness ideas.
Popular Posts
-
Five ways agriculture could benefit from artificial intelligence. Agriculture is the industry that accompanied the evolution of humanity ...
-
. Yeasts vary greatly, not only in their unique genetic strains, but also in the way they are produced, cultured, used and the extent to ...
-
Experimental vaccine to be used against Ebola outbreak in the DRC.A campaign to vaccinate people at risk of developing Ebola in the lates...
-
The world is faced with the issue of drug-resistance, super bugs and antibiotic residue in animal-by-products,forcing producers to look ...
-
This is a complete guide on dog care, free download. Dog Blog — Articles, Guides, Reviews, Interviews & News About Dogs ...
-
The avian influenza virus ravaging poultry in some countries now and death of humans in other countries, have been linked to migratory b...
AGRIBUSINESS EDUCATION.
Translate
I-CONNECT -AGRICULTURE
AGRIBUSINESS TIPS.
AGRIBUSINESS.
The Agriculture Daily
veterinarymedicineechbeebolanle-ojuri.blogspot.com Cassava: benefits of garri as a fermented food. Cassava processing involves fermentation which is a plus for gut health. The fermentation process removes the cyanogenic glucosides present in the fres...